Akira Ando Selected Research

Therapeutics

5/2020	High-flow nasal cannula therapy for acute respiratory failure in patients with interstitial pneumonia: a retrospective observational study.
1/2017	Inhibitory effect of a redox-silent analogue of tocotrienol on hypoxia adaptation in prostate cancer cells.
9/2014	Granulocyte colony-stimulating factor-producing carcinoma of unknown primary site.
10/2011	[Oxycodone and pregabalin using transdermal fentanyl patch provided relief of symptoms for postherpetic neuropathic pain in a patient with non-small cell lung cancer].
8/2010	Anti-aquaporin-4 antibody-positive optic neuritis treated with double-filtration plasmapheresis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akira Ando Research Topics

Disease

10	Neoplasms (Cancer) 01/2019 - 07/2002
7	Bursitis (Adhesive Capsulitis) 01/2021 - 05/2015
7	Contracture 01/2015 - 01/2007
5	COVID-19 04/2023 - 01/2022
5	Fibrosis (Cirrhosis) 10/2022 - 01/2008
5	Hypoxia (Hypoxemia) 06/2019 - 01/2013
4	Mesothelioma 01/2019 - 05/2009
4	Gyrate Atrophy 03/2011 - 11/2003
4	Rupture 01/2003 - 04/2002
3	Inflammation (Inflammations) 09/2020 - 04/2015
3	Lung Neoplasms (Lung Cancer) 06/2019 - 12/2015
3	Pain (Aches) 05/2015 - 10/2011
3	Glaucoma 04/2013 - 09/2005
3	Retinal Neovascularization 01/2003 - 04/2002
3	Choroidal Neovascularization 09/2002 - 04/2002
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2020
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2021 - 01/2017
2	Diabetes Mellitus 12/2020 - 05/2015
2	Prostatic Neoplasms (Prostate Cancer) 08/2018 - 01/2017
2	Carcinoma (Carcinomatosis) 08/2018 - 09/2014
2	Malignant Mesothelioma 01/2018 - 01/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 10/2011
2	Hypertrophy 04/2015 - 01/2011
2	Congenital Abnormalities (Deformity) 06/2014 - 08/2008
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 04/2013 - 07/2003
2	Low Tension Glaucoma 10/2009 - 07/2003
2	Cataract (Cataracts) 12/2008 - 11/2005
2	Atrophy 12/2008 - 11/2005
2	Ischemia 01/2003 - 09/2002
1	Bacteremia 04/2023
1	Idiopathic Pulmonary Fibrosis 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Lung Injury 01/2021
1	Fistula 01/2021
1	Shoulder Fractures 09/2020
1	Respiratory Insufficiency (Respiratory Failure) 05/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2020
1	Aneurysm (Aneurysms) 01/2020

Drug/Important Bio-Agent (IBA)

7	Capsules (Microcapsules)IBA 09/2020 - 01/2007
6	TocotrienolsIBA 01/2019 - 05/2009
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 04/2002
5	Retinal Pigments (Pigments, Visual)IBA 03/2011 - 11/2003
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 07/2002
4	OrnithineIBA 03/2011 - 11/2003
4	Transaminases (Aminotransferases)IBA 03/2011 - 11/2003
4	Retinaldehyde (Retinal)IBA 01/2003 - 04/2002
3	SteroidsIBA 04/2023 - 05/2015
3	Oxygen (Dioxygen)IBA 05/2020 - 04/2002
3	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2019 - 12/2015
3	TensinsIBA 01/2017 - 12/2015
3	CollagenIBA 04/2015 - 01/2010
3	Messenger RNA (mRNA)IBA 03/2011 - 01/2003
2	Silicon Dioxide (Silica)FDA LinkGeneric 10/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2021
2	NF-kappa B (NF-kB)IBA 09/2020 - 01/2018
2	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 06/2019 - 12/2015
2	CateninsIBA 06/2019 - 01/2016
2	LipidsIBA 08/2018 - 01/2018
2	Fatty Acid-Binding ProteinsIBA 08/2018 - 01/2018
2	CytokinesIBA 01/2018 - 01/2017
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017 - 01/2016
2	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2016 - 12/2015
2	Proteoglycans (Proteoglycan)IBA 04/2015 - 01/2011
2	Hyaluronic Acid (Hyaluronan)IBA 01/2015 - 08/2008
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2011 - 09/2002
2	pigment epithelium-derived factorIBA 11/2005 - 07/2002
2	Protein Isoforms (Isoforms)IBA 09/2002 - 04/2002
1	Anti-Infective Agents (Microbicides)IBA 04/2023
1	Vasodilator Agents (Vasodilators)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	4- (3'- (2'- chlorophenyl)- 2'- propen- 1'- ylidene)- 1- phenyl- 3,5- pyrazolidinedioneIBA 01/2022
1	Interferon Type IIBA 01/2022
1	Small Cytoplasmic RNAIBA 12/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2021
1	ChemokinesIBA 01/2021
1	AminesIBA 01/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020
1	Cadherins (E-Cadherin)IBA 06/2019
1	Doxycycline (Periostat)FDA LinkGeneric 06/2019
1	ProteomeIBA 10/2018
1	Estrogens (Estrogen)FDA Link 08/2018
1	Carrier Proteins (Binding Protein)IBA 08/2018
1	Ether (Diethyl Ether)IBA 01/2018
1	Protein Kinase CIBA 01/2018
1	MethyltransferasesIBA 01/2018
1	Monoacylglycerol LipasesIBA 01/2018

Therapy/Procedure

5	Therapeutics 05/2020 - 08/2010
4	Joint Capsule Release 01/2021 - 05/2015
4	Lasers (Laser) 01/2003 - 04/2002
2	Oral Administration 01/2019 - 09/2002
2	Conservative Treatment 01/2018 - 03/2013
2	Radiotherapy 12/2017 - 01/2017
2	Drug Therapy (Chemotherapy) 01/2017 - 01/2017
2	Trabeculectomy (Trabeculoplasty) 04/2013 - 11/2009
1	Ligation 01/2021
1	Intramedullary Fracture Fixation 09/2020
1	Aftercare (After-Treatment) 09/2020
1	Cannula 05/2020
1	Brachial Plexus Block 01/2018